[Treatment with beta-phenylisopropyl-hydrazine (Catran) in anancastic disease states. Report on 3 current cases].
D006834:Hydrazines / Q000628:therapy*; D009497:Neurotic Disorders; D009771:Obsessive-Compulsive Disorder / Q000628:therapy*; D011600:Psychopharmacology
D006834:Hydrazines; C029424:hydrazine
HYDRAZINES/therapy; NEUROSES, OBSESSIVE COMPULSIVE/therapy; PSYCHOPHARMACOLOGY